| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
Moiz Rehmanjee
DFI | Director of Finance/CFO | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 30/09/2016 | |
| Chairman | - | 26/10/2017 | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 24.88M | ||
| -0.46% | +10.31% | +63.52% | +143.15% | 1,257B | ||
| -0.97% | +1.60% | +43.25% | +80.09% | 651B | ||
| -2.05% | +0.73% | +32.47% | +101.62% | 510B | ||
| -0.49% | -0.75% | +52.60% | +66.91% | 388B | ||
| -0.78% | +5.51% | +72.55% | +44.25% | 366B | ||
| +0.38% | +2.55% | +32.72% | +58.46% | 303B | ||
| -0.12% | +8.08% | +12.08% | +34.94% | 288B | ||
| -0.12% | +4.68% | +55.97% | +74.59% | 252B | ||
| -0.21% | +7.34% | +42.19% | +109.69% | 211B | ||
| Average | -0.41% | +4.59% | +45.26% | +79.30% | 469.63B | |
| Weighted average by Cap. | -0.44% | +5.30% | +49.19% | +93.65% |
Employees
-
Sector
Pharmaceuticals
















